Ad is loading...
FATE
Price
$2.02
Change
-$0.06 (-2.88%)
Updated
Nov 15 closing price
106 days until earnings call
SANA
Price
$2.42
Change
-$0.17 (-6.56%)
Updated
Nov 15 closing price
116 days until earnings call
Ad is loading...

FATE vs SANA

Header iconFATE vs SANA Comparison
Open Charts FATE vs SANABanner chart's image
Fate Therapeutics
Price$2.02
Change-$0.06 (-2.88%)
Volume$1.75M
CapitalizationN/A
Sana Biotechnology
Price$2.42
Change-$0.17 (-6.56%)
Volume$2.64M
CapitalizationN/A
FATE vs SANA Comparison Chart
Loading...
FATE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SANA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
FATE vs. SANA commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FATE is a Sell and SANA is a Sell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (FATE: $2.02 vs. SANA: $2.42)
Brand notoriety: FATE and SANA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FATE: 137% vs. SANA: 181%
Market capitalization -- FATE: $230.07M vs. SANA: $540.31M
FATE [@Biotechnology] is valued at $230.07M. SANA’s [@Biotechnology] market capitalization is $540.31M. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FATE’s FA Score shows that 1 FA rating(s) are green whileSANA’s FA Score has 1 green FA rating(s).

  • FATE’s FA Score: 1 green, 4 red.
  • SANA’s FA Score: 1 green, 4 red.
According to our system of comparison, both FATE and SANA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FATE’s TA Score shows that 4 TA indicator(s) are bullish while SANA’s TA Score has 4 bullish TA indicator(s).

  • FATE’s TA Score: 4 bullish, 4 bearish.
  • SANA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both FATE and SANA are a good buy in the short-term.

Price Growth

FATE (@Biotechnology) experienced а -16.53% price change this week, while SANA (@Biotechnology) price change was -19.47% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

FATE is expected to report earnings on Mar 03, 2025.

SANA is expected to report earnings on Mar 13, 2025.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SANA($540M) has a higher market cap than FATE($230M). SANA YTD gains are higher at: -40.686 vs. FATE (-45.989). FATE has higher annual earnings (EBITDA): -176.34M vs. SANA (-229.49M). FATE has more cash in the bank: 305M vs. SANA (252M). SANA (98.6M) and FATE (101M) have identical debt. FATE has higher revenues than SANA: FATE (12.3M) vs SANA (0).
FATESANAFATE / SANA
Capitalization230M540M43%
EBITDA-176.34M-229.49M77%
Gain YTD-45.989-40.686113%
P/E RatioN/AN/A-
Revenue12.3M0-
Total Cash305M252M121%
Total Debt101M98.6M102%
FUNDAMENTALS RATINGS
FATE: Fundamental Ratings
FATE
OUTLOOK RATING
1..100
59
VALUATION
overvalued / fair valued / undervalued
1..100
19
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
93
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FATESANA
RSI
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
86%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 14 days ago
86%
Bullish Trend 14 days ago
77%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
87%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
89%
View a ticker or compare two or three
Ad is loading...
FATE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SANA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JIESX14.840.02
+0.13%
JPMorgan Developed International Value I
STEYX12.97-0.10
-0.77%
AB International Strat Eqs Adv
TPVIX21.47-0.17
-0.79%
Timothy Plan Small Cap Value I
SNWAX62.85-0.66
-1.04%
Easterly Snow Small Cap Value A
ATECX115.01-1.66
-1.42%
AB Sustainable Global Thematic C

FATE and

Correlation & Price change

A.I.dvisor indicates that over the last year, FATE has been loosely correlated with ALLO. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if FATE jumps, then ALLO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FATE
1D Price
Change %
FATE100%
-2.88%
ALLO - FATE
55%
Loosely correlated
-7.72%
ABCL - FATE
54%
Loosely correlated
-3.99%
INZY - FATE
53%
Loosely correlated
-8.89%
NTLA - FATE
53%
Loosely correlated
-7.61%
BEAM - FATE
52%
Loosely correlated
-8.59%
More

SANA and

Correlation & Price change

A.I.dvisor indicates that over the last year, SANA has been loosely correlated with BEAM. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if SANA jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SANA
1D Price
Change %
SANA100%
-6.56%
BEAM - SANA
43%
Loosely correlated
-8.59%
AXON - SANA
43%
Loosely correlated
-0.86%
VERV - SANA
42%
Loosely correlated
-10.97%
RXRX - SANA
40%
Loosely correlated
-10.64%
FATE - SANA
40%
Loosely correlated
-2.88%
More